Neoplasms, Colorectal Recruiting Phase 1 / 2 Trials for Cediranib (DB04849)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02484404Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal CancersTreatment